New Advancement in the field of Epidemiology:

The advancement of epidemiology depends on developments in epidemiologic methods and in research findings. For both, new technologies are highly important. It is, for example, difficult to understand the strong growth in epidemiologic data-analysis without the emergence of the computer, or of molecular and genetic epidemiology without major advances in molecular technology. The purpose of this editorial is to invite articles on the new technologies that are likely to play a crucial role in the further development of epidemiology and of epidemiologic research.

For the practice of epidemiology and its methods, we already see the first glimpses of the introduction of modern information technology. We have witnessed the application of new technology in the remarkable explosion of genome-wide association studies (GWAs) of various diseases and traits. We also see the first results of new imaging studies and the emergence of the exceedingly important field of population imaging.

The “hypothesis free” approach in the GWAs, i.e. approach without the use of prior knowledge, has been considerably more productive than the candidate gene approach. This is sobering for those of us who have an optimistic view on what we know, and has led to the conclusion that “most recent findings are false”. The GWAs have also led to large-scale collaborations in epidemiology in a form and quantity that we had not witnessed before, although it remains to be seen whether this is a lasting phenomenon.

The new imaging practices that are currently applied in population studies are likely to be the beginning of an avalanche in epidemiologic studies of many diseases. These imaging techniques enable epidemiologists to study disease at a previous stage than when a clinical diagnosis can be made, allow for objective assessment of the disease or trait, and make repeated assessment possible. These features are likely to be very advantageous, in particular for etiologic epidemiologic research.

The European Journal of Epidemiology publishes quite frequently descriptions of new studies and presents also occasionally updates of these studies’ objectives and design. We invite in particular new studies that make use of new technologies and we will also certainly, consider manuscripts on the technical details of these technologies that are applied in epidemiologic research.

#Epidemiology #Infectious #Diseases #microbiology

For more details contact:

Isabella Ross | Program Manager | EuroEpidemiology2019

Mail id: euroepidemiology@memeetings.net

Tuberculosis research reports- TB drugs increases susceptibility to Mtb-reinfection

Tuberculosis treatment in recent times should give permanent cure for TB infection which is being caused by Mycobacterium tuberculosis (Mtb). But the TB research was worried after knowing that there is no prevention for reinfection. Here are the reasons why?

A recent publication revealed that the anti-TB drugs changes the activity of gut microbiota and increases the susceptibility to Mtb infection. Gut microbiota are crucial to keep us healthy; they involve in food digestion, fights pathogenic microbes and protects our immune system. Recent research has reported that chronic use of antibiotic (TB Drugs) leads to disruption of this microbiome, which can in turn lead to dysregulation of the immune system. It remains unclear, however, whether changes in the composition of the microbes living in our gut have an influence on TB infection.

In an experimental treatment for Tuberculosis with anti-TB drugs like isoniazid, rifampicin and pyrazinamide for a period of eight weeks, they found that all of them significantly changed the composition of the specimen gut microbiome, but the only specimen treated with isoniazid combined with pyrazinamide showed an increase in susceptibility to Mtb infection. This study can be completely understood by knowing the Epidemiology of TB, relationship of Lungs to gut microbiota.

To know about these details visit Mtb reinfection and to share your scientific experiences on such conditions take part in workshops and symposium carried on rare diseases (Tuberculosis is said to be one of the rare diseases). We believe that Euro Epidemiology congress will give some details on advanced research on these deadly and dangerous diseases and controllable disorders for better human healthcare.

What is SDG? And what is the role of Epidemiology in SDG?

Sustainable Development Goals (SDG’s) otherwise known as Global Goals which are universal call to action to end the world’s poverty, to protect the planet and to ensure that everyone enjoying their peace and prosperity.

There are total of 17 Global goals that include No Poverty, Zero Hunger, Good Health and Well-being (Public Health/ Global Healthcare), Quality Education, Gender Equality, Clear Water and Sanitation, Affordable and Clean Energy, Decent Work and Economic Growth, Industry Innovations and Infrastructure, Required Inequalities, Sustainable Cities and Communications, Responsible Consumption and Production, Climate Action, Life Below Water, Life and Land, Peace, Justice and strong Institutions, and finally Partnerships for the Goals. The Good Health and Well-Being can be considered for Global Healthcare and Public Health Protection which is significantly related to Disease Control Epidemiology, Pathological Epidemiology, and Infectious Diseases Epidemiology.

The 9^th European Epidemiology and Public Health Congress is such a conference holding not only the related regular Health related studies and also dealing with SDG’s through the Disease Control, Pathological Studies and Infectious Diseases Control. This conference is going to be carried out some very important oral presentations on the SDG’s studies by eminent speakers from a developed and developing countries.

Visit here for more details https://goo.gl/jYjb9i

Cancer Epidemiology-A brief study for better Healthcare

Cancer epidemiology is the analysis of the distribution, determinants, and frequency of cancer conditions in specific populations it includes the study of factors influencing and results the malignancy along with distribution, determinants and frequency of malignant diseases in specific population. The cancer studies are involved with three types of epidemiological research which are analytic epidemiology, descriptive epidemiology and clinical epidemiology responsible for identification of causes, diseases frequency, and screening programs respectively.

In recent times cancer research is significantly active. The Institute for Quantum Computing (IQC) from University of Waterloo’s researchers has developed a new quantum sensor that could mean recognizable advancements in 3D imaging and monitoring for cancer patients.

The team has developed a sensor which is semiconductor nano-wires based that is able to detect single light particles with high resolution and speed. The new sensor’s efficiency is spectacular over a wide range from the ultraviolet to near-infrared. This sensor can improve quantum communication and has better sensing capabilities say the researchers. The researchers said that this technology can reach a significant development in long range high-resolution 3D-imaging, singlet-oxygen-particle detection, quantum communication. These are useful for dose monitoring in cancer treatment.

Best Poster Reward-Euro Epidemiology 2019

We took the pleasure of informing the interested participants regarding the Best Poster Reward on student poster competition at the event 9th European Epidemiology and Public Health Congress scheduled to be held at Helsinki, Finland during 29-30 of April. Through the collaboration partnership #AccdonLLC #LetPub awarding the best presentation in poster with the $500 travel reward for students.

Euro Epidemiology 2019 brings professionals together from every corner of the world who share a commitment to reduce the global burden of diseases and disorders with the theme “An emerging trans disciplinary and interdisciplinary evaluation” anticipating for a huge number healthcare professionals, working in and beyond Molecular Pathological Epidemiology to share experiences and best practices through invited keynote, plenary lectures, symposium, workshops, and posters covering a wide  range of topics and important issues which affect us all from the research to the experimental implementations.

All interested participants are allowed and invited to give their proposals and presentations on their research and review works in the field of Epidemiology, Public Health, Global Healthcare, Chronic Disorders, Infectious Diseases,etc...

You can contact us through email euroepidemiology@memeetings.net or else just #comment here for more details.

Do eating Cashew Nuts leads Weight Gain?

Cashews are said to be leading to weight gain if we eat in higher quantities. Actually cashews are rich sources of copper, iron, magnesium, selenium, and phosphorus and they have many health benefits because if their nutritional values.  Cashews have high amount of healthy fatty acids and antioxidants. Including cashews in regular diet has been linked to improving cardiovascular health, lowering cholesterol levels, and even weight loss and hence it can be declared as a myth that eating cashew leads to weight gain.

Unprocessed cashews are poisonous and one cannot eat the raw cashews, the processed nuts make for a delicious, healthy snack that give above mentioned benefits to your health. Cashews are not toxic but the shell around them contains of toxic oils said to be urushiol which causes dermatitis. This agent is acidic in nature and also causes skin rashes, itching, and blisters when it comes in contact with the skin.

What do cashews contain?

Cashews reported to contain dietary fiber, vitamin K, a range of healthy minerals like copper, magnesium, and manganese, and omega-3 fatty acids. Cashews are more beneficial than peanuts as they contain higher quantities of Omega-3 fatty acids than omega-6 fatty acids. Cashews are also a good energy source and it gives about 10% of your daily protein that your body needs when we take 18 medium-sized cashew nuts as it contain about 5 g protein.

Nutritional Diet helps in overcoming the unhealthy conditions and gives enough strength to fight back the weakness while attacked by diseases. Study on nutrients definitely helps for best healthcare.

How to treat Rare Cancer?

Researchers from New York's Rockefeller University announced the discovery of a rare tumor type which is not able to synthesize cholesterol, and a molecule without cholesterol can't survive. Those cells will become dependent on cholesterol from any other source, and this dependency strategy of the cancer cell helps us to design therapies to block cholesterol uptake from their environment.

Cancer cells are impressive in their relentless growth, sidestepping in the aging process as they become immortal, and avoid the immune system's persistent attacks. But in the process of acquiring such superior powers, the cells must occasionally suppress other, more unusual activities--including the ability to produce certain nutrients. In rare cancers they lose the ability to make vital nutrients for their survival. As a first line of treatment against these cancer cells, doctors give patients a drug (inactive enzyme) known as asparaginase, which breaks down the amino acid bond from the cancer cell, removing it from the blood. Without access to its environment for the nutrient, the cancer cells die.

Cancer Epidemiology is the most important topic than any other epidemiological studies as it directly leads the death of the victim. Cancers are not curable unless we observe the symptoms in the early stages and we are aware of the epidemiology through clinical methods. Some rare cancers are said to be curable through the above mentioned strategical studies, we support thanking all the professional cancer epidemiologists and researchers who are giving their life to build a better healthy environment all over the globe.